CombiGene´s lead project CG01 has received funding from the European Union´s Horizon 2020 research and innovation programme

CombiGene announces the result of the offer to the holders of shares and warrants in Panion and extends the acceptance period

Jun 25, 2019

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in Australia, Brazil, the Faroe Islands, United Arab Emirates, Hong Kong, India, Japan, Canada, New Zealand, Switzerland, Saudi Arabia, Singapore, South Africa, South Korea, Taiwan or the United States or in any other jurisdiction there in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.

  • When the initial acceptance period was due, the shareholders in Panion had accepted to transfer in total 19,903,923 Shares and 3,592,066 Warrants due to the Offer, corresponding to approximately 81.58 per cent of the total number of outstanding Shares and votes in Panion, and 79.27 per cent of the total number of outstanding warrants in Panion
  • CombiGene is extending the acceptance period for the Offer until 3:00 p.m. on 10 July 2019

Press release >>